购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 10-14周
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "dha-taxol"的结果
筛选
搜索结果
TargetMol产品目录中 "

dha-taxol

"的结果
  • 抑制剂&激动剂
    1
    TargetMol | Inhibitors_Agonists
  • LY3325656
    T700051998714-25-2
    LY3325656 is a GPR142 agonist suitable for clinical testing in human. LY3325656 demonstrated anti-diabetic benefits in pre-clinical studies and ADME PK properties suitable for human dosing. LY3325656 is the first GPR142 agonist molecule advancing to phase 1 clinic trials for the treatment of Type 2 diabetes.
    Others
    • ¥ 16100
    10-14周
    规格
    数量